He Ji, Wu BaoQiao, Zhang Yue, Dai Limiao, Ji Juan, Liu Yueming, He Qiang
Jinzhou Medical University, Jinzhou, Liaoning, China.
Urology & Nephrology Center, Department of Nephrology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Ren Fail. 2024 Jan 30;46(1):2312533. doi: 10.1080/0886022X.2024.2312533. Epub 2024 Feb 23.
Currently, there is no consensus on the optimal timing for the initiation of peritoneal dialysis (PD) after catheter placement.
Systematic review and meta-analysis.
From inception till July 31, 2023.
To assess the outcomes and safety of unplanned PD initiation (<14/7 days after catheter insertion) in cohort studies.
Fifteen studies involving 3054 participants were included. (1) The risk of unplanned initiation of leakage and Obstruction was no difference in both the break-in period (BI) <14 and BI < 7 groups. (2) Catheter displacement was more likely to occur in the emergency initiation group with BI < 7. (3) No significant differences were observed between the two groups regarding infectious complications. (4) There was no difference in transition to HD between patients with BI < 7 and BI < 14 d.
Infectious complications of unplanned initiation of peritoneal dialysis did not differ from planned initiation. Emergency initiation in the BI < 7 group had higher catheter displacement, but heterogeneity was higher. There were no differences in leakage or obstruction in either group. Catheter survival was the same for emergency initiation of peritoneal dialysis compared with planned initiation of peritoneal dialysis and did not increase the risk of conversion to hemodialysis.
This meta-analysis was registered on PROSPERO (https://www.crd.york.ac.uk/PROSPERO/, number: CRD42023431369).
目前,关于导管置入后开始腹膜透析(PD)的最佳时机尚无共识。
系统评价和荟萃分析。
从开始至2023年7月31日。
评估队列研究中计划外开始腹膜透析(导管插入后<14/7天)的结局和安全性。
纳入15项研究,共3054名参与者。(1) 在磨合期(BI)<14天和BI<7天的组中,计划外开始渗漏和梗阻的风险没有差异。(2) 导管移位更有可能发生在BI<7天的紧急开始组中。(3) 两组在感染并发症方面未观察到显著差异。(4) BI<7天和BI<14天的患者向血液透析的转变没有差异。
计划外开始腹膜透析的感染并发症与计划内开始无差异。BI<7天组的紧急开始导管移位率更高,但异质性更高。两组在渗漏或梗阻方面均无差异。与计划内开始腹膜透析相比,紧急开始腹膜透析的导管存活率相同,且不会增加转为血液透析的风险。
本荟萃分析已在PROSPERO(https://www.crd.york.ac.uk/PROSPERO/,编号:CRD42023431369)上注册。